Preclinical approaches to the development of effective immunotherapeutic protocols for the treatment of metastasis.
D000818:Animals; D002986:Clinical Trials as Topic; D004195:Disease Models, Animal; D004353:Drug Evaluation, Preclinical; D005260:Female; D006801:Humans; D007167:Immunotherapy / Q000379:methods*; D007376:Interleukin-2 / Q000627:therapeutic use; D007694:Killer Cells, Natural / Q000276:immunology; D008262:Macrophage Activation; D008325:Mammary Neoplasms, Experimental / Q000139:chemically induced / Q000628:therapy; D008770:Methylnitrosourea; D051379:Mice; D009362:Neoplasm Metastasis; D009381:Neoplasms, Radiation-Induced / Q000628:therapy; D011713:Pyran Copolymer / Q000627:therapeutic use; D051381:Rats; D011994:Recombinant Proteins / Q000627:therapeutic use; D012878:Skin Neoplasms / Q000628:therapy
D007376:Interleukin-2; D011994:Recombinant Proteins; D011713:Pyran Copolymer; D008770:Methylnitrosourea